A slight dip in EPS growth is expected, but sustained strong performance in net income to $32.20 billion and revenue growth ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

AbCellera Biologics ( (ABCL) ) has shared an update. AbCellera reported its Q3 2024 financial results, highlighting a strategic expansion with ...

Stock futures slipped in overnight trading Sunday as investors geared up for the highly-anticipated U.S. presidential ...

Read an update on dividend stocks with strong growth potential and resilience, perfect for navigating election volatility and ...

Even with this partial rebound, Lilly's share price remains roughly 13% below the peak set in late August. Some investors ...

The U.S. presidential election will be held on November 5, 2024, but there’s another event that investors may want to vote on ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) shares rose 0.9% during trading on Tuesday following a dividend announcement from the company. The company traded as high as $907.98 and last traded ...

The ASX may dip as Wall Street fell overnight Meta’s projections ... Q3 earnings and revenue that fell short of analysts’ ...

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound ...